96 results
Pathophysiology - Pathogenesis of Chronic Kidney Disease

#Pathophysiology #Nephrology #Chronic #Kidney #Disease #CKD
Pathophysiology ... Chronic Kidney Disease ... #Pathophysiology ... #Nephrology #Chronic ... #Kidney #Disease
Algorithm for the Treatment of Parkinson Disease With Predominant Postural Instability and Gait Impairment

#Management #Neurology #Parkinsons
Algorithm for the Treatment ... of Parkinson Disease ... #Management #Neurology ... #Parkinsons #Disease ... #Medication #Treatment
Alzheimer's Disease - Summary
 • Epidemiology
 • Pathophysiology
 • Risk Factors
 • Presentation
 • Diagnosis
 •
Alzheimer's Disease ... Epidemiology • Pathophysiology ... Diagnosis • Treatment ... #Alzheimers #Disease
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... of renal bone disease ... the first-line treatments ... #Pharmacology #Pathophysiology
â–º
Gastritis and Peptic Ulcer Disease - Etiology, Diagnostics, Treatment and Complications

#Diagnosis #Pathophysiology #Management #Gastritis #PepticUlcerDisease #PUD
and Peptic Ulcer Disease ... , Diagnostics, Treatment ... #Diagnosis #Pathophysiology
Complications of CKD
 - Patients with stages 1-3 ([GFR] >30 mL/min) of CKD are generally asymptomatic;
1-3 ([GFR] >30 mL ... 4-5 (GFR < 30 mL ... #Pathophysiology ... #Nephrology #CKD
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Chronic Kidney Disease ... : • GFR < 60 ml ... Acute Kidney Diseases ... months No Kidney Disease ... #Definitions #nephrology
Algorithm for the Treatment of Uremic Pruritus
Nonpharmacologic Treatments:
 • Daily topical emollient
 • Avoidance of extremes
Algorithm for the Treatment ... Nonpharmacologic Treatments ... Pharmacologic Treatments ... nalfurafine 2.5 mcg ... #management #nephrology
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
interstitial lung disease ... >10% (or >200 mL ... DLCO >15% (or 3 mL ... Symptomatic treatment ... optimization of GERD treatment
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Metformin Treatment ... Chronic Kidney Disease ... VisualAbstract #Nephrology